If liver fat reduction is a key objective, retatrutide offers substantially greater hepatic fat clearance than tirzepatide, as discussed above
Among the dozens of compounds studied in pre-clinical and early research settings, two names consistently rise to the top of scientific literature and researcher discussions: BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta-4 Fragment)
On January 6, 2025, the Department of Justice announced that Athira Pharma agreed to pay $4,068,698 to settle False Claims Act allegations
Funding This review received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
BPC-157 and TB-500 are frequently researched together for their distinct mechanisms, and the blend provides both in one vial for convenience in research workflows